Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point by another two years to 2028. BTIG raised the firm’s price target on ...

咪喹莫特（R837）是一种免疫佐剂，通过激活先天免疫系统中的TLR7受体，增强免疫细胞对肿瘤或病毒感染的免疫反应，常用于肿瘤免疫治疗和抗病毒治疗。介孔聚多巴胺（MPDA）纳米粒是一种具有良好生物相容性和高表面积的智能纳米材料，能够负载和控释药物 ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

Vaccines may be contributing to an alarming rise in excess deaths. Doctors and healthcare professionals across the world have signed a petition calling for the immediate suspension of all COVID-19 ...

Scientists at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have divulged compounds acting as Toll-like receptor 7 (TLR7) and TLR8 agonists reported to be useful for the treatment of cancer.

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...

Pre-Market: 9:02:49 a.m. EST ...

This data feed is not available at this time.

Several doctors and healthcare professionals have signed a petition calling for the immediate suspension of all COVID-19 mRNA products because they fear the jabs could be contributing to an alarming ...